Skip to main content

Utility of contrast-enhanced ultrasound for solid mass surveillance and characterization in children with tuberous sclerosis complex: an initial experience

Abstract

Background

Patients with tuberous sclerosis complex (TSC) can develop solid kidney masses from childhood. Imaging surveillance is done to detect renal cell carcinoma (RCC) and angiomyolipomas (AML), including AMLs at risk for hemorrhage. Intravenous contrast-enhanced ultrasound (CEUS) may be useful for screening as ultrasound is well tolerated by children and ultrasound contrast agents (UCA) are not nephrotoxic.

Methods

Retrospective review of kidney CEUS exams of pediatric TSC patients. Qualitative CEUS analysis by consensus of 3 radiologists assessed rate, intensity, and pattern of lesion enhancement. Quantitative CEUS analysis was performed using Vuebox®. Where available, abdominal MRI was analyzed qualitatively for the same features and quantitatively by in-house-developed software. Time-intensity curves were generated from both CEUS and MRI where possible. Appearance of lesions were compared between CEUS and MRI and histology where available.

Results

Nine masses in 5 patients included one histologically proven RCC and 8 AMLs diagnosed by imaging. Quantitative CEUS of RCC showed malignant features including increased peak enhancement 162%, rapid wash-in rate 162%, and elevated washout rate 156% compared to normal kidney tissue; versus AML which was 68%, 105%, and 125%, respectively. All masses were hypoenhancing on MRI compared to normal kidney tissue; MR dynamic contrast study offered no distinction between RCC and AML. The only MRI feature differentiating RCC from AML was absence of fat.

Conclusion

Temporal resolution afforded by CEUS was useful to distinguish malignant from benign kidney masses. CEUS may prove useful for screening, characterizing, and follow-up of kidney lesions in pediatric TSC patients.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Slegtenhorst MV, Hoogt RD, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, Ouweland AVD, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Snell M, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808

    PubMed  Google Scholar 

  2. The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome-16. Cell 75:1305–1315

    Google Scholar 

  3. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A 99:13571–13576

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Henske EP, Jozwiak S, Kingswood JC, Sampson JR, Thiele EA (2016) Tuberous sclerosis complex. Nat Rev Dis Prim 2:16035

    PubMed  Google Scholar 

  5. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777–1782

    CAS  PubMed  Google Scholar 

  6. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141–145

    CAS  PubMed  Google Scholar 

  7. Casper KA, Donnelly LF, Chen B, Bissler JJ (2002) Tuberous sclerosis complex: renal imaging findings. Radiology 225:451–456

    PubMed  Google Scholar 

  8. Narla LD, Slovis TL, Watts FB, Nigro M (1988) The renal lesions of tuberosclerosis (cysts and angiomyolipoma): screening with sonography and computerized tomography. Pediatr Radiol 8:205–209

    Google Scholar 

  9. Lemaitre L, Robert Y, Dubrulle F, Claudon M, Duhamel A, Danjou P, Mazeman E (1995) Renal angiomyolipoma: growth followed up with CT and/or US. Radiology 197:598–602

    CAS  PubMed  Google Scholar 

  10. Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP (1998) Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83:2208–2216

    CAS  PubMed  Google Scholar 

  11. Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E, Colato C, Bernstein J (1998) Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 22:180–187

    CAS  PubMed  Google Scholar 

  12. Allison JW, James CA, Figarola MS (1999) Pediatric case of the day. Renal cell carcinoma in a child with tuberous sclerosis. Radiographics 19:1388–1389

    CAS  PubMed  Google Scholar 

  13. Lendvay TS, Broecker B, Smith EA (2002) Renal cell carcinoma in a 2-year-old child with tuberous sclerosis. J Urol 168:1131–1132

    PubMed  Google Scholar 

  14. Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66:924–934

    PubMed  Google Scholar 

  15. Rabenou RA, Charles HW (2015) Differentiation of sporadic versus tuberous sclerosis complex-associated angiomyolipoma. AJR Am J Roentgenol 205:292–301

    PubMed  Google Scholar 

  16. Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986) The management of renal angiomyolipoma. J Urol 135:1121–1124

    CAS  PubMed  Google Scholar 

  17. Kessler OJ, Gillon G, Neuman M, Engelstein D, Winkler H, Baniel J (1998) Management of renal angiomyolipoma: analysis of 15 cases. Eur Urol 33:572–575

    CAS  PubMed  Google Scholar 

  18. Seyam RM, Bissada NK, Kattan SA, Mokhtar AA, Aslam M, Fahmy WE, Mourad WA, Binmahfouz AA, Alzahrani HM, Hanash KA (2008) Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology 72:1077–1082

    PubMed  Google Scholar 

  19. Clarke A, Hancock E, Kingswood C, Osborne JP (1999) End-stage renal failure in adults with the tuberous sclerosis complex. Nephrol Dial Transplant 14:988–991

    CAS  PubMed  Google Scholar 

  20. Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255–265

    PubMed  PubMed Central  Google Scholar 

  21. Buj Pradilla MJ, Marti Balleste T, Torra R, Villacampa Auba F (2017) Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. Clin Kidney J 10:728–737

    PubMed  PubMed Central  Google Scholar 

  22. Correas JM, Claudon M, Tranquart F, Hélénon AO (2006) The kidney: imaging with microbubble contrast agents. Ultrasound 22:53–66

    Google Scholar 

  23. Mazziotti S, Zimbaro F, Pandolfo A, Rac-chiusa S, Settineri N, Ascenti G (2010) Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 35:241–245

    PubMed  Google Scholar 

  24. Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, Russo P (2011) Evaluation of renal masses with contrast enhanced ultrasound: initial experience. AJR Am J Roentgenol 197:897–906

  25. Ignee A, Straub B, Brix D, Schuessler G, Ott M, Dietrich CF (2010) The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc 46:275–290

    PubMed  Google Scholar 

  26. Quaia E, Bertolotto M, Cioffi V, Rossi A, Baratella E, Pizzolato R, Assunta Cov M (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast- enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol 191:1239–1249

  27. Barr RG, Peterson C, Hindi A (2014) Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology 271:133–142

    PubMed  Google Scholar 

  28. Rafailidis V, Deganello A, Watson T, Sidhu PS, Sellars ME (2017) Enhancing the role of paediatric ultrasound with microbubbles: a review of intravenous applications. Br J Radiol 90:20160556

    PubMed  Google Scholar 

  29. Darge K, Papadopoulou F, Ntoulia A, Bulas DL, Coley BD, Fordham LA, Paltiel HJ, McCarville B, Volberg FM, Cosgrove DO, Goldberg BB, Wilson SR, Feinstein SB (2013) Safety of contrast enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol 43:1063–1073

    PubMed  Google Scholar 

  30. Anupindi SA, Biko DM, Ntoulia A, Poznick L, Morgan TA, Darge K, Back SJ (2017) Contrast-enhanced US assessment of focal liver lesions in children. Radiographics 37:1632–1647. https://doi.org/10.1148/rg.2017170073

    Article  PubMed  Google Scholar 

  31. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, Parker L, Gonzalez ABD (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukemia and brain tumors: a retrospective cohort study. Lancet 380:499–505

    PubMed  PubMed Central  Google Scholar 

  32. Brenner DJ, Elliston CD, Hall EJ, Berdon WE (2001) Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 176:289–296

    CAS  PubMed  Google Scholar 

  33. Goske MJ, Applegate KE, Boylan J, Butler PF, Callahan MJ, Coley BD, Farley S, Frush DP, Hernanz-Schulman M, Jaramillo D, Johnson ND, Kaste SC, Morrison G, Strauss KJ, Alliance for radiation safety in pediatric imaging (2008) Image Gently®: a national education and communication campaign in radiology using the science of social marketing. J Am Coll Radiol 5:1200–1205

    PubMed  Google Scholar 

  34. Schulte-Uentrop L, Goepfert MS (2010) Anaesthesia or sedation for MRI in children. Curr Opin Anaesthesiol 23:513–517

    PubMed  Google Scholar 

  35. Slovis TL (2011) Sedation and anesthesia issues in pediatric imaging. Pediatr Radiol 41:514–516

    PubMed  Google Scholar 

  36. Largo-Pineda CE, Arenas-Correa ID, Ángel-González GJ, Vélez-Arango JM, Calvo-Betancur VD, Arango-Zapata AN (2017) Adverse events in paediatric patients taken to magnetic resonance imaging under sedation or anaesthesia. Colombian J Anesthesiol 45:8–14

    Google Scholar 

  37. Vanderby SA, Babyn PS, Carter MW, Jewell SM, Mckeever PD (2010) Effect of anesthesia and sedation on pediatric MR imaging patient flow. Radiology 256:229–237. https://doi.org/10.1148/radiol.10091124

    Article  PubMed  Google Scholar 

  38. Khrichenko D, Darge K (2010) Functional analysis in MR urography – made simple. Pediatr Radiol 40:182–199

    PubMed  Google Scholar 

  39. Wilson SR, Kim TK, Jang HJ, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189:W7–W12

  40. Jang HJ, Yu H, Kim TK (2009) Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging 9:96–103

    PubMed  PubMed Central  Google Scholar 

  41. Schieda N, Kielar AZ, Al Dandan O, McInnes MD, Flood TA (2015) Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation. Clin Radiol 70:206–220

    CAS  PubMed  Google Scholar 

  42. Vos N, Oyen R (2018) Renal angiomyolipoma: the good, the bad, and the ugly. J Belg Soc Radiol 102:41

    PubMed  PubMed Central  Google Scholar 

  43. Richmond L, Atri M, Sherman C, Sharir S (2010) Renal cell carcinoma containing macroscopic fat on CT mimics an angiomyolipoma due to bone metaplasia without macroscopic calcification. Br J Radiol 83:e179–e181

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Patel U, Simpson E, Kingswood JC, Saggar-Malik AK (2005) Tuberous sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol 60:665–673

    CAS  PubMed  Google Scholar 

  45. Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, Anderson C, Zonnenberg BA (2016) Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: current data and future study. Nephron 134:51–58

    CAS  PubMed  Google Scholar 

  46. Wang C, Li X, Peng L, Gou X, Fan J (2018) An update on recent developments in rupture of renal angiomyolipoma. Medicine (Baltimore) 97:e0497

    Google Scholar 

  47. Patil AR, Chandra R, Gupta A, Thukral BB (2010) Giant aneurysm formation in sporadic renal angiomyolipoma. J Radiol Case Rep 4:21–27

    PubMed  PubMed Central  Google Scholar 

  48. Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K (2002) Renal Angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225:78–82. https://doi.org/10.1148/radiol.2251011477

    Article  PubMed  Google Scholar 

  49. Durkin N, Deganello A, Sellars ME, Sidhu PS, Davenport M, Makin E (2016) Post-traumatic liver and splenic pseudoaneurysms in children: diagnosis, management, and follow-up screening using contrast enhanced ultrasound (CEUS). J Pediatr Surg 51:289–292

    PubMed  Google Scholar 

  50. Back SJ, Andronikou S, Kilborn T, Kaplan BS, Darge K (2015) Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome. Pediatr Radiol 45:386–395

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chan Joyce PK.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chan, J.P., Back, S.J., Vatsky, S. et al. Utility of contrast-enhanced ultrasound for solid mass surveillance and characterization in children with tuberous sclerosis complex: an initial experience. Pediatr Nephrol 36, 1775–1784 (2021). https://doi.org/10.1007/s00467-020-04835-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-020-04835-6

Keywords

  • Contrast-enhanced ultrasound
  • CEUS
  • Children
  • Kidney
  • TSC
  • Mass